In summary, the results of the present study have shown that SKI-II is able to reverse the chemoresistance of SGC7901/DDP gastric cancer cells by decreasing the levels of P-gp and MRP-1, which increases the concentrations of DDP in the SGC7901/DDP cells. The gene discussed is PGP; the disease is gastric cancer.